newsfilter
← Latest News
GlobeNewswire·

Trevena Regains Compliance with Nasdaq Listing Requirements

CHESTERBROOK, Pa., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system